VASCADE ANTEGRADE-PVD Post-Market Registry

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

January 19, 2017

Primary Completion Date

September 18, 2017

Study Completion Date

September 18, 2017

Conditions
Surgical Wound
Interventions
DEVICE

Cardiva Medical VASCADE VCS

At the end of peripheral endovascular interventional procedures performed via an antegrade femoral arterial approach, the femoral arterial access site is closed with the VASCADE VCS to achieve arterial hemostasis.

Trial Locations (5)

28401

Coastal Surgery Specialists, Wilmington

38801

North MS Medical Center, Tupelo

44195

Cleveland Clinic Foundation, Cleveland

70360

Cardiovascular Institute of the South, Houma

78258

San Antonio Endovascular and Heart Institute, San Antonio

Sponsors
All Listed Sponsors
lead

Cardiva Medical, Inc.

INDUSTRY